Fig. 3From: Cost per DALY averted in low, middle- and high-income countries: evidence from the global burden of disease study to estimate the cost-effectiveness thresholdsa Trend of health expenditure per capita (PPP $ 2011 international) by countries based on HDI. b ASR DALY rate per 100,000 due to all causes by countries from 2000 to 2016Back to article page